HGH Fragment 176-191
A fragment of the growth hormone molecule studied in metabolism research.
- Type
- Peptide
- Research area
- Metabolic research
- Research stage
- Laboratory and animal research
- FDA status
- Not an FDA-approved medicine
About HGH Fragment 176-191
A fragment of the growth hormone molecule studied in metabolism research.
Where the research stands
Most published work on this compound comes from laboratory, animal or early human studies. Results in those settings don't always carry over to people, and long-term safety data are limited.
Read the studies
Educational information only; not medical advice. Talk to a licensed doctor before using any compound.
Common questions
Is HGH Fragment 176-191 an FDA-approved medicine?
No. HGH Fragment 176-191 is not an FDA-approved medicine. Research stage: Laboratory and animal research.
Does EKO Labs sell HGH Fragment 176-191?
No. EKO Labs does not sell HGH Fragment 176-191 or any research compound. This library is for education only. EKO Labs offers FDA-approved prescription treatments only after a licensed doctor decides they are right for you.
Can people use HGH Fragment 176-191?
This page does not cover personal use. Products labeled "research use only" are not made or approved for people. Ask a licensed doctor before using any compound.
What is the molecular formula of HGH Fragment 176-191?
According to PubChem (U.S. National Library of Medicine), HGH Fragment 176-191 has the molecular formula C80H127N23O24S2 and a molar mass of about 1,859.1 g/mol.
The molecule: HGH Fragment 176-191
Drag to rotate. Every atom and bond below comes from the public PubChem database of the U.S. National Institutes of Health; nothing is drawn by AI.
- Formula
- C80H127N23O24S2
- Molar mass
- 1,859.1 g/mol
- Heavy atoms
- 129
- PubChem CID
- 172966176 ↗
Source: PubChem, National Library of Medicine (public domain).
Related compounds
C18H14N2O2SLU-PP-332SLU-PP-332
A small molecule (not a peptide) studied in mouse research on exercise-like metabolic effects.
C201H319N49O65S2EloralintideEloralintide
Investigational amylin-receptor medicine in clinical trials. Not FDA-approved.
C194H312N54O59S2CagriSemaCagriSema
Investigational combination of cagrilintide and semaglutide in clinical trials. Not FDA-approved.